Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.

D-471 (Fourth Floor), Above Wholesale Market, Gala Gymkhana Road, South Bopal, Bopal, Ahmedabad, Gujarat-380058

info@qxpts.com

+91 99798 42207/ +91 99798 94611

Let’s Stay In Touch

Shopping cart

Subtotal $0.00

View cartCheckout

    Download

    Regulatory Support

    • Home
    • Regulatory Support
    Curved Image

    • QxP Pharma Consultants: Ensuring Seamless Regulatory Navigation for Pharma, Biotech, and Medical Devices

    • At QxP Pharma Consultants, we offer comprehensive Pharma Regulatory Support services to help pharmaceutical, biotechnology, and medical device companies meet international regulatory requirements efficiently.
    • Whether you’re launching a new drug, conducting a clinical trial, or preparing a dossier for a medical device, our experts provide end-to-end regulatory support across the entire product lifecycle.

    • Why Choose QxP Pharma Consultants for Regulatory Affairs?


    • Your Trusted Partner for Global Regulatory Excellence

    • With decades of experience and a team of seasoned professionals, QxP Pharma Consultants in Ahmedabad have become a trusted name for GMP Services Providing in Ahmedabad and GMP Services Providing in India.
    • Our clients value our ability to simplify the regulatory pathway, avoid delays, and accelerate market access through tailored Regulatory Strategy and Support.
    • Our expertise spans:
    • FDA Regulatory Support Services
    • EU Regulatory Affairs Support
    • WHO Regulatory Support
    • MOH Regulatory Support (Ministries of Health in various countries)

    • Comprehensive Pharmaceutical Regulatory Support Services


    • 1. Regulatory Documentation Support

    • Accurate and well-organized documentation is the backbone of regulatory compliance. Our team provides full-spectrum Regulatory Documentation Support services including:
    • Common Technical Document (CTD) preparation
    • Investigator brochures
    • Module-wise compilation and review
    • Summary of Product Characteristics (SmPC)
    • Risk Management Plans (RMPs)
    • We ensure that every document aligns with the latest global guidelines, facilitating smooth submission and approval.

    • 2. Regulatory Submission Support

    • Our Regulatory Submission Support services are designed to assist you in managing submissions efficiently for new drugs, generics, biologics, and medical devices. We handle:
    • New Drug Applications (NDAs)
    • Abbreviated New Drug Applications (ANDAs)
    • Investigational New Drug (IND) submissions
    • Marketing Authorization Applications (MAAs)
    • eCTD publishing and validation
    • By streamlining the submission process, we help reduce delays and increase your chances of first-cycle approvals.

    • 3. Regulatory Strategy and Lifecycle Support

    • A well-defined regulatory roadmap is essential for product success. Our team offers customized Regulatory Strategy and Supports to align your development plan with global regulatory expectations.
    • Our Lifecycle Regulatory Supports Services ensure ongoing compliance from clinical development through post-marketing phases, including:
    • Variations and amendments
    • Renewals and annual updates
    • Labeling and packaging updates
    • We help manage every phase of the regulatory lifecycle efficiently and compliantly.

    • 4. Clinical Trial Regulatory Support

    • Clinical trials must meet stringent ethical and regulatory standards. Our Clinical Trial Regulatory Supports ensures full compliance with ICH GCP, local ethics committees, and global regulatory bodies.
    • Our services include:
    • Clinical trial applications (CTAs)
    • Informed consent forms (ICFs) and study protocols
    • Site regulatory document preparation and management
    • Liaison with ethics committees and health authorities

    • 5. CMC Regulatory Support

    • Chemistry, Manufacturing, and Controls (CMC) documentation is a crucial component of regulatory filings. We provide CMC Regulatory Supports for:
    • Drug substance and product development reports
    • Process validation protocols
    • Manufacturing site compliance
    • Analytical method validation and stability data
    • We ensure your CMC sections are comprehensive, compliant, and audit-ready.

    • Specialized Regulatory Supports Areas


    • GMP Regulatory Supports

    • As a core part of QxP Pharma Consultants & GMP Services, we specialize in GMP Regulatory Supports, helping companies ensure compliance with Good Manufacturing Practices during inspections and audits. Our team offers:
    • Mock GMP audits
    • CAPA planning and implementation
    • Facility readiness assessments
    • SOP reviews and updates

    • Regulatory Supports for Drug Approvals

    • Bringing a product to market demands strategic planning and execution. Our Regulatory Supports Consultant for Drug Approvals includes:
    • Pre-submission meetings with regulatory authorities
    • Dossier preparation and submission
    • Response to deficiency letters and RFIs
    • Post-approval compliance activities

    • Medical Device Regulatory Supports

    • For manufacturers of devices, we offer complete Medical Device Regulatory Supports, including:
    • Device classification and registration
    • Technical file and design dossier preparation
    • CE marking and FDA 510(k) submission
    • PMS and vigilance reporting

    • Pharma Consultants in India You Can Trust

    • As one of the top Pharma Consultants in India, QxP stands apart by delivering:
    • Customized, cost-effective solutions
    • In-depth knowledge of global regulatory frameworks
    • Proactive project management and communication
    • Strict adherence to timelines and quality
    • We serve clients across generics, branded drugs, biosimilars, vaccines, APIs, and medical devices.

    • Why Regulatory Compliance Matters?

    • Failure to comply with regulatory guidelines can lead to:
    • Delays in product approvals
    • Costly recalls and rework
    • Legal penalties and reputational damage
    • Loss of market share
    • Partnering with QxP Pharma Consultants ensures you’re always a step ahead in achieving full regulatory compliance.

    • Frequently Asked Questions (FAQs)

    • Q1: What is regulatory support in pharma manufacturing and why is it essential for GMP compliant plant operations in India?
    • Regulatory support in pharma manufacturing covers all ongoing activities required to maintain, renew, and expand regulatory approvals from CDSCO, WHO-GMP, EU-GMP, and other global health authorities. It includes license renewal, variation management, CAPA handling, inspection response, and post-approval changes. In India, no pharma plant can sustain commercial operations without continuous regulatory support. Professional regulatory support ensures your facility remains fully compliant between inspections and avoids costly shutdowns or Warning Letters.

    • Q2: What ongoing regulatory support activities does a GMP compliant pharma manufacturing plant need in India?
    • A GMP compliant pharma plant in India requires continuous regulatory support across multiple areas. These include Drug Manufacturing License renewal, product variation submissions, CDSCO query responses, WHO-GMP surveillance inspection preparation, Annual Product Review (APR) compilation, CAPA management, and change control documentation. Facilities targeting export markets need ongoing EU-GMP, USFDA, or MHRA compliance maintenance. Each activity requires accurate, timely, and ALCOA+ compliant documentation to sustain regulatory standing and avoid market withdrawal risks.

    • Q3: How does regulatory support help pharma companies manage CDSCO inspections and WHO-GMP surveillance audits in India?
    • Professional regulatory support prepares pharma facilities for CDSCO inspections and WHO-GMP surveillance audits through systematic mock audits, gap assessments, and SOP reviews. It ensures all qualification, validation, and batch manufacturing records are current and inspection-ready. In India, facilities without dedicated regulatory support frequently receive critical observations during surprise inspections. Structured regulatory support eliminates this risk. It keeps all documentation aligned with current Schedule M, WHO-GMP, and EU-GMP requirements at all times.

    • Q4: What documents must be maintained through ongoing regulatory support for a GMP pharma plant in India?
    • Ongoing regulatory support in Gujarat includes Site Master File updates, license renewal applications, product variation dossiers, Annual Product Reviews, stability study updates, change control records, deviation and CAPA logs, SOP revision histories, and requalification reports. WHO-GMP and EU-GMP additionally require quality risk management records and supplier qualification updates. All documents must follow ALCOA+ principles. Gaps in any document category create critical vulnerabilities during CDSCO or WHO-GMP regulatory inspections.

    • Q5: What are the most common regulatory support failures that cause GMP compliance breakdowns for pharma plants in India?
    • Common regulatory support failures include expired Drug Manufacturing Licenses, outdated SOPs, unresolved CAPA actions, and missed Annual Product Review deadlines. Inadequate change control documentation and absent requalification records after equipment modifications are equally problematic. In India, CDSCO and WHO-GMP inspectors treat these as critical GMP deficiencies. Such failures trigger Warning Letters, product recalls, manufacturing suspensions, and loss of export certifications. Continuous regulatory support prevents all these avoidable compliance breakdowns effectively.

    • Q6: Can QXP Pharma Project Consultant & GMP Service Pvt. Ltd. provide ongoing regulatory support for pharma plant GMP compliance in India?
    • Yes. QXP Pharma Project Consultant & GMP Service Pvt. Ltd. provides comprehensive ongoing regulatory support for pharma plants across India. Services include Site Master File maintenance, license renewal management, CDSCO and WHO-GMP inspection preparation, CAPA resolution, variation submission, Annual Product Review preparation, and regulatory query responses. Their team ensures continuous Schedule M, WHO-GMP, and EU-GMP compliance between inspections. Clients maintain clean regulatory standing and avoid costly compliance breakdowns throughout their commercial manufacturing lifecycle.

    • Q7: How does a properly executed Computer System Validation (CSV) strategy protect pharma plant data integrity and accelerate GMP approval in India?
    • A strong CSV strategy ensures all GxP critical systems maintain accurate and tamper-proof electronic records. It guarantees full ALCOA+ and 21 CFR Part 11 compliance. In India, structured CSV programs help facilities pass WHO-GMP and CDSCO inspections with fewer observations. Early CSV planning saves 2 to 4 months on the overall project schedule. It eliminates repeat validation runs and ensures smooth commercial production from day one of regulatory approval.

    • Get in Touch with QxP Pharma Consultants

    • Are you looking for Pharmaceutical Regulatory Supports that guarantees compliance and accelerates your time to market?
    • Contact us today to learn how our Regulatory Affairs Support Services can support your success in a regulated market.
    • Partner with QxP — Where Regulatory Excellence Meets Industry Experience.